[go: up one dir, main page]

WO2010115735A2 - Procédés d'inactivation de virus - Google Patents

Procédés d'inactivation de virus Download PDF

Info

Publication number
WO2010115735A2
WO2010115735A2 PCT/EP2010/054029 EP2010054029W WO2010115735A2 WO 2010115735 A2 WO2010115735 A2 WO 2010115735A2 EP 2010054029 W EP2010054029 W EP 2010054029W WO 2010115735 A2 WO2010115735 A2 WO 2010115735A2
Authority
WO
WIPO (PCT)
Prior art keywords
ammonium
virus
chloride
haloperoxidase
bromide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2010/054029
Other languages
English (en)
Other versions
WO2010115735A3 (fr
Inventor
Morten Gjermansen
Rikke Festersen
Steffen Danielsen
Marie Allesen-Holm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Priority to CN2010800144898A priority Critical patent/CN102368906A/zh
Priority to JP2012502604A priority patent/JP2012522743A/ja
Priority to US13/259,843 priority patent/US20120020946A1/en
Priority to EP10711220A priority patent/EP2413700A2/fr
Publication of WO2010115735A2 publication Critical patent/WO2010115735A2/fr
Publication of WO2010115735A3 publication Critical patent/WO2010115735A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/02—Inorganic compounds ; Elemental compounds
    • C11D3/04—Water-soluble compounds
    • C11D3/046—Salts
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38654—Preparations containing enzymes, e.g. protease or amylase containing oxidase or reductase
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/39—Organic or inorganic per-compounds
    • C11D3/3947—Liquid compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A61L2/186—Peroxide solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/22—Phase substances, e.g. smokes, aerosols or sprayed or atomised substances
    • A61L2103/15—
    • A61L2103/50—
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
    • C11D2111/10—Objects to be cleaned
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16061—Methods of inactivation or attenuation
    • C12N2740/16063—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32661—Methods of inactivation or attenuation
    • C12N2770/32663—Methods of inactivation or attenuation by chemical treatment

Definitions

  • the invention also covers a composition which results from applying the method of the invention.
  • the composition comprises a haloperoxidase, hydrogen peroxide, chloride ions and/or bromide ions, ammonium ions, active or inactive viruses, and a medical device or equipment.
  • the method of the invention is useful for decontamination of locations which have been exposed to viruses, such as biological warfare agents.
  • the term "disinfecting” or “disinfection” refers to high level disinfection according to "Content and Format of Premarket Notification [510(k)] submissions for Liquid Chemical Sterilants/High Level Disinfectants", U.S. Food and Drug Administration, Jan. 2000.
  • the methods according to the invention may be carried out at a temperature between 0 and 70 degrees Celsius, preferably between 5 and 60 degrees Celsius, more preferably between 10 and 60 degrees Celsius, even more preferably between 15 and 60 degrees Celsius, even more preferably between 20 and 60 degrees Celsius, most preferably between 20 and 50 degrees Celsius, and in particular between 20 and 40 degrees Celsius.
  • the method of the invention is suitable for inactivating viruses in a variety of environments.
  • the method of the invention may desirably be used in any environment to reduce virus infections, such as the health-care industry (e.g. animal hospitals, human hospitals, animal clinics, human clinics, nursing homes, day-care facilities for children or senior citizens, etc.), the food industry (e.g. restaurants, food-processing plants, food-storage plants, grocery stores, etc.), the hospitality industry (e.g. hotels, motels, resorts, cruise ships, etc.), the education industry (e.g. schools and universities), etc.
  • the health-care industry e.g. animal hospitals, human hospitals, animal clinics, human clinics, nursing homes, day-care facilities for children or senior citizens, etc.
  • the food industry e.g. restaurants, food-processing plants, food-storage plants, grocery stores, etc.
  • the hospitality industry e.g. hotels, motels, resorts, cruise ships, etc.
  • the education industry e.g. schools and universities
  • the method of the invention may desirably be used in any environment to reduce virus infections, such as general-premise surfaces (e.g. floors, walls, ceilings, exterior of furniture, etc.), specific-equipment surfaces (e.g. hard surfaces, manufacturing equipment, processing equipment, etc.), textiles (e.g. cottons, wools, silks, synthetic fabrics such as polyesters, polyolefins, and acrylics, fiber blends such as cottonpolyester, etc.), wood and cellulose- based systems (e.g. paper), soil, animal carcasses (e.g. hide, meat, hair, feathers, etc.), foodstuffs (e.g. fruits, vegetables, nuts, meats, etc.), and water.
  • general-premise surfaces e.g. floors, walls, ceilings, exterior of furniture, etc.
  • specific-equipment surfaces e.g. hard surfaces, manufacturing equipment, processing equipment, etc.
  • textiles e.g. cottons, wools, silks, synthetic fabrics such as polyesters, polyolefin
  • the viruses which are contacted by the composition of the invention may be located on any surface including, but not limited to, a surface of a process equipment used in e.g. a dairy, a chemical or pharmaceutical process plant, a medical device such as an endoscope or other medical utensils, a piece of laboratory equipment, a washing machine, or a water sanitation system.
  • the composition of the invention should be used in an amount, which is effective for inactivating the viruses on the surface in question.
  • the method of the invention is also useful for decontamination of locations which have been exposed to viruses (e.g. pathogenic viruses), such as biological warfare agents.
  • viruses e.g. pathogenic viruses
  • Such locations include, but are not limited to, clothings (such as army clothings), inner and outer parts of vehicles, inner and outer parts of buildings, any kind of army facility, and any kind of environment mentioned above.
  • the poliovirus strain Sabin (Type 2H.010704) obtained from WHO was propagated in VERO cells at 34.5°C, 5% CO 2 using Eagles MEM 2% FCS, 100 IU/mL penicillin, 100 mg/mL streptomycin, and 20 ⁇ g/mL gentamycin. Culture supernatant was filtered (0.45 nm), aliquoted and stored at -80 0 C until use.
  • the undiluted disinfecting solution was further diluted with phosphate buffered saline (PBS) to give 1 :10 and 1 :100 solutions.
  • PBS phosphate buffered saline
  • Eagles MEM media supplemented with 4% fetal calf serum, 100 IU/mL penicillin, 100 mg/mL streptomycin and 20 ⁇ g/mL gentamycin.
  • sodium hypochlorite was used as a control at concentrations of 0.5%, 0.05% and 0.005%
  • the results show that the method of the invention inhibited poliovirus (lane 2-4) to the same extend as sodium hypochlorite (lane 5-7).
  • the assay was performed in duplicate.
  • the enzyme system showed strong virucidal activity, even down to a 1 :100 dilution.
  • Solution 1 22.8 mM NaCI and 7.2 mM NH 4 CI in 20 mM DMG (Sigma D4379) buffer pH 7.0;
  • Solution 2 10% H 2 O 2 in MiIIiQ water;
  • Solution 3 8000 ppm haloperoxidase from Curvularia verrucolosa (see SEQ ID NO:2 in WO 97/04102) in 20 mM DMG buffer pH 7.0; Phosphate buffered saline
  • RPMI1640 Glutamax (Sigma R8758) supplemented with 100 IU/mL penicillin, 100 mg/mL Streptomycin, 20 ⁇ g/mL gentamycin, 10 IU/mL Nystatin and 5% fetal calf serum.
  • test solution 50 ⁇ L was mixed with 50 ⁇ L of a diluted HIV virus stock in PBS and incubated at 37°C for 5 min.
  • sodium hypochlorite was used as a control at concentrations of 0.5%, 0.05% and 0.005%.
  • concentrations of 0.5%, 0.05% and 0.005% were used for all treatments.
  • a control without virus addition was made in order to identify any cytotoxic effects of the test solutions on the cell line.
  • a positive control of virus infectivity was included in which no disinfecting solution was added.
  • Absorbance was measured in a plate reader at 540 nm with absorbance at 690 nm as reference. Based on the absorbance, each well was scored to be either infected or non- infected in the virus containing wells; and toxic or non-infected in the control wells for cytotoxicity.
  • T Toxic The results show that the method of the invention had an antiviral effect on HIV virus in a 1 :100 dilution (lane 4) during an incubation period of 5 min.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dentistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La présente invention concerne un procédé permettant d'inactiver des virus, par mise en contact des virus avec une halogénoperoxydase, du peroxyde d'hydrogène, des ions chlorure, des ions bromure, et des ions ammonium.
PCT/EP2010/054029 2009-04-03 2010-03-26 Procédés d'inactivation de virus Ceased WO2010115735A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN2010800144898A CN102368906A (zh) 2009-04-03 2010-03-26 用于灭活病毒的方法
JP2012502604A JP2012522743A (ja) 2009-04-03 2010-03-26 ウイルスを不活性化するための方法
US13/259,843 US20120020946A1 (en) 2009-04-03 2010-03-26 Methods for Inactivating Viruses
EP10711220A EP2413700A2 (fr) 2009-04-03 2010-03-26 Procédés d'inactivation de virus

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP09157351 2009-04-03
EP09157351.9 2009-04-03
EP09158525 2009-04-22
EP09158525.7 2009-04-22

Publications (2)

Publication Number Publication Date
WO2010115735A2 true WO2010115735A2 (fr) 2010-10-14
WO2010115735A3 WO2010115735A3 (fr) 2011-08-11

Family

ID=42936626

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/054029 Ceased WO2010115735A2 (fr) 2009-04-03 2010-03-26 Procédés d'inactivation de virus

Country Status (5)

Country Link
US (1) US20120020946A1 (fr)
EP (1) EP2413700A2 (fr)
JP (1) JP2012522743A (fr)
CN (1) CN102368906A (fr)
WO (1) WO2010115735A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014051710A1 (fr) * 2012-09-27 2014-04-03 Halliburton Energy Services, Inc. Procédé de conversion d'un biocide inactif en un biocide actif au moyen d'une réaction chimique

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9102326B2 (en) 2012-03-05 2015-08-11 Embry-Riddle Aeronautical University, Inc. Hybrid assembly for an aircraft
CN110496525A (zh) * 2019-08-30 2019-11-26 山东多芬农业有限公司 空气净化剂及其制备和使用方法
CN111363729B (zh) * 2020-03-12 2021-04-16 苏州白垩纪生物科技有限公司 一种rna病毒灭活保存液及其应用
MX2022016056A (es) * 2020-06-29 2023-02-02 Sintx Technologies Inc Sistemas y metodos para la inactivacion rapida del coronavirus tipo 2 causante del sindrome respiratorio agudo severo (sars-cov-2) mediante nitruro de silicio y nitruro de aluminio.

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995027046A2 (fr) 1994-03-31 1995-10-12 Unilever Nv Compositions antimicrobiennes enzymatiques comprenant des haloperoxydases
WO1995029996A1 (fr) 1994-05-03 1995-11-09 Novo Nordisk A/S Glucose-oxydase alcaline
WO1997004102A1 (fr) 1995-07-14 1997-02-06 Novo Nordisk A/S Haloperoxydases provenant de curvularia verruculosa et acides nucleiques les codant
WO1999031990A1 (fr) 1997-12-22 1999-07-01 Novo Nordisk A/S Oxydase d'hydrate de carbone et utilisation de cette derniere dans la cuisson
WO2000050606A1 (fr) 1999-02-24 2000-08-31 Novozymes Biotech, Inc. Polypeptides presentant une activite d'oxydase de galactose et acides nucleiques codant ces polypeptides
US6248575B1 (en) 1998-05-18 2001-06-19 Novozymes Biotech, Inc. Nucleic acids encoding polypeptides having L-amino acid oxidase activity
WO2001079460A2 (fr) 2000-04-14 2001-10-25 Novozymes A/S Polypeptides a activite haloperoxydase
WO2001079458A2 (fr) 2000-04-14 2001-10-25 Novozymes A/S Polypeptides ayant une activite d'haloperoxidase
WO2001079461A2 (fr) 2000-04-14 2001-10-25 Novozymes A/S Polypeptides a activite haloperoxydase
WO2001079459A2 (fr) 2000-04-14 2001-10-25 Novozymes A/S Polypeptides ayant une activite d'haloperoxydase et acides nucleiques qui les codent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04275202A (ja) * 1991-02-25 1992-09-30 Kesler Jack 非毒性酵素的滅菌剤
CN1265561A (zh) * 1997-08-14 2000-09-06 诺沃挪第克公司 含有卤素过氧化物酶、过氧化氢源、卤化物源和铵源的抗微生物组合物
JP2002003317A (ja) * 2000-06-21 2002-01-09 Mitsubishi Gas Chem Co Inc 殺菌剤組成物
JP2002128618A (ja) * 2000-10-20 2002-05-09 Mitsubishi Gas Chem Co Inc 殺菌剤組成物
AU2003239773A1 (en) * 2002-06-28 2004-01-19 Novozymes A/S Preparation of vaccines
WO2009053438A1 (fr) * 2007-10-23 2009-04-30 Novozymes A/S Procédés pour tuer des spores et désinfecter ou stériliser des dispositifs
WO2010122100A1 (fr) * 2009-04-22 2010-10-28 Novozymes A/S Procédés pour tuer ou inhiber la croissance de mycobactéries

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995027046A2 (fr) 1994-03-31 1995-10-12 Unilever Nv Compositions antimicrobiennes enzymatiques comprenant des haloperoxydases
WO1995029996A1 (fr) 1994-05-03 1995-11-09 Novo Nordisk A/S Glucose-oxydase alcaline
WO1997004102A1 (fr) 1995-07-14 1997-02-06 Novo Nordisk A/S Haloperoxydases provenant de curvularia verruculosa et acides nucleiques les codant
WO1999031990A1 (fr) 1997-12-22 1999-07-01 Novo Nordisk A/S Oxydase d'hydrate de carbone et utilisation de cette derniere dans la cuisson
US6248575B1 (en) 1998-05-18 2001-06-19 Novozymes Biotech, Inc. Nucleic acids encoding polypeptides having L-amino acid oxidase activity
WO2000050606A1 (fr) 1999-02-24 2000-08-31 Novozymes Biotech, Inc. Polypeptides presentant une activite d'oxydase de galactose et acides nucleiques codant ces polypeptides
WO2001079460A2 (fr) 2000-04-14 2001-10-25 Novozymes A/S Polypeptides a activite haloperoxydase
WO2001079458A2 (fr) 2000-04-14 2001-10-25 Novozymes A/S Polypeptides ayant une activite d'haloperoxidase
WO2001079461A2 (fr) 2000-04-14 2001-10-25 Novozymes A/S Polypeptides a activite haloperoxydase
WO2001079459A2 (fr) 2000-04-14 2001-10-25 Novozymes A/S Polypeptides ayant une activite d'haloperoxydase et acides nucleiques qui les codent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Class II Special Controls Guidance Document: Medical Washers and Medical Washer-Disinfectors; Guidance for the Medical Device Industry and FDA Review Staff", U.S. FOOD AND DRUG ADMINISTRATION, February 2002 (2002-02-01)
"Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/High Level Disinfectants", U.S. FOOD AND DRUG ADMINISTRATION, January 2000 (2000-01-01)
J. IMM. METH, vol. 65, pages 55 - 63

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014051710A1 (fr) * 2012-09-27 2014-04-03 Halliburton Energy Services, Inc. Procédé de conversion d'un biocide inactif en un biocide actif au moyen d'une réaction chimique
US8791054B2 (en) 2012-09-27 2014-07-29 Halliburton Energy Services, Inc. Methods of converting an inactive biocide into an active biocide using a chemical reaction

Also Published As

Publication number Publication date
JP2012522743A (ja) 2012-09-27
EP2413700A2 (fr) 2012-02-08
CN102368906A (zh) 2012-03-07
US20120020946A1 (en) 2012-01-26
WO2010115735A3 (fr) 2011-08-11

Similar Documents

Publication Publication Date Title
Lin et al. Sanitizing agents for virus inactivation and disinfection
AU2003302067B2 (en) Hydrogen peroxide disinfectant containing an acid and/or an alcohol
De Benedictis et al. Inactivation of avian influenza viruses by chemical agents and physical conditions: a review
US4828912A (en) Virucidal product having virucidal and/or germicidal properties
US4897304A (en) Virucidal composition, the method of use and the product therefor
JP5829293B2 (ja) カリシウイルス不活化方法
GB2103089A (en) Use of carboxylic acids as virucides
US20120020946A1 (en) Methods for Inactivating Viruses
US20090104172A1 (en) Methods for killing spores and disinfecting or sterilizing devices
US20190071621A1 (en) Process for removal of biofilm
WO2013012007A1 (fr) Composition d'agent anti-virus
US20070274978A1 (en) Method of Killing Spores
EP2362732B1 (fr) Procédé d obtention d un niveau élevé de désinfection dans un autolaveur et autolaveur
Huang et al. Efficacy of EPA‐registered disinfectants against two human norovirus surrogates and Clostridioides difficile endospores
Maillard et al. Virucidal activity of microbicides
Sloan et al. Mechanical wiping increases the efficacy of liquid disinfectants on SARS-CoV-2
US20120034203A1 (en) Methods for Killing or Inhibiting Growth of Mycobacteria
Bieker Chemical inactivation of viruses
WO2023145619A1 (fr) Composition d'inactivation de virus non enveloppé
CN107318885A (zh) 家用水槽用特效杀菌片
WO2022266040A2 (fr) Solutions de désinfection à usages multiples
Huang et al. E cacy of commercially available disinfectants against human norovirus surrogates and Clostridioides difficile endospores

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080014489.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10711220

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2010711220

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13259843

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2012502604

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10711220

Country of ref document: EP

Kind code of ref document: A2